The United Kingdom early Mitoxantrone Copaxone trial is currently in its initial recruitment phase. Updated information will be posted here as the trial progresses further.
Ethics and research governance approval has now been granted for all 10 centres involved in the trial. Five centres (Liverpool, Manchester, Sheffield, Leeds and Nottingham) have randomised patients, with 20 patients recruited to date.
A further 40 patients are still required and we hope to complete recruitment in 2007.
The paper describing the initial experience of the Liverpool group with Mitoxantrone/Copaxone was published in the September issue of the Journal of Neurology. The abstract can be downloaded at http://springerlink.com/content/c4665hn327j67770/?p=055587d4e09c45b1b96b3a540cdb99a3&pi=5